Disparity in Funding and Research Efforts between Feds and Private Industry Limiting Research in Regenerative Medicine, According to BCC Research

Wellesley, MA (PRWEB) June 15, 2015 Regenerative medicine receives more than 10 times as much private funding as government funding. While private-industry research typically focuses on developing an end product in a singular field (e.g., biology, chemistry) government research tends to be in the form of grants to laboratories focused more on fundamental research that ...

Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm.

Southlake, Texas (PRWEB) March 05, 2015 RMI specializes in Stemnexa™ non-surgical treatment of acute and chronic orthopedic conditions such as meniscal tears, ACL injuries, rotator cuff injuries, runner’s knee, tennis elbow, and joint pain due to degenerative conditions like osteoarthritis. Stemnexa may also be administered during orthopedic surgeries to promote better post-surgical outcomes. Stemnexa ...

Global Regenerative Medicine Market: 20.16% CAGR to 2019 Forecasts a New Research Report at ReportsnReports.com

Dallas, Texas (PRWEB) December 18, 2014 The rise in prevalence of degenerative diseases is one of the main factors which is driving the growth of the global regenerative medicine market. Regenerative medicine is involved in the process of replacing or regenerating human tissues, cells and/or organs for normal functioning of the body. Small molecules and ...

The Alliance for Regenerative Medicine Announces Its Third Annual Regen Med Investor Day & Initial Slate of Presenting Companies

The Alliance for Regenerative Medicine Announces Its Third Annual Regen Med Investor Day & Initial Slate of Presenting Companies
WASHINGTON, DC (PRWEB) February 03, 2015 The Alliance for Regenerative Medicine (ARM) today announced its annual Regen Med Investor Day will take place March 25, 2015 in New York City, co-hosted by top financial firm Piper Jaffray. Now in its third year, this one-day meeting remains the only investment event organized specifically to provide institutional, ...